Phase III trial of vandetanib compared with erlotinib in patients with previously trreated advanced non-small-cell lung cancer - Natale, Ronald B.; Thongprasert, Sumitra; Greco, F. Anthony; Thomas, Michael; Tsai, Chun-Ming; Sunpaweravong, Patrapim; Ferry, David; Mulatero, Clive; Whorf, Robert; Thompson, Joyce; Barlesi, Fabrice; Langmuir, Peter; et al. (Journal of clinical oncology, 2011)
Gesehen am 21.09.2022